|
COPYRIGHT 2001 NewsRX
2001 APR 23 - (NewsRx.com & NewsRx.net) --
Treatment and outcomes for patients with chronic hepatitis (HCV) continue to improve with the recent approval of pegylated interferon.
An expert panel, convened by the American College of Gastroenterology (ACG) on April 6, 2001, met in Dallas, Texas, to discuss the...
Read the full article for free courtesy of your local library.
|